Newsroom

WASHINGTON & BERLIN--(BUSINESS WIRE)--Association of Medical Device Reprocessors issued the following statement: Friday’s unanimous verdict by a federal jury in Santa Ana, California for Innovative Health against Johnson & Johnson (NYSE: JNJ) is a victory for America’s hospitals, providers, patients, and the environment. The jury found that Biosense Webster violated federal and state antitrust laws by withholding clinical support to hospitals using Innovative Health’s FDA regulated, reproce...

紐約--(BUSINESS WIRE)--(美國商業資訊)-- 全球性投資人權益法律事務所Rosen Law Firm提醒投資人，一名股東代表在2023年3月17日至2024年11月17日期間購買Sana Biotechnology, Inc. (NASDAQ: SANA)證券的投資人提起了集體訴訟。Sana是一家生物科技公司。 如欲瞭解更多資訊，請遞交表格、向Phillip Kim律師寄送電子郵件，或致電866-767-3653聯絡我們。 指控內容：Rosen Law Firm正在調查對Sana Biotechnology, Inc. (NASDAQ: SANA)在其業務營運方面誤導投資人的指控。 起訴書指稱，在集體訴訟期內，被告做出了虛假和/或誤導性陳述及/或未揭露：(1) Sana面臨重大風險，其資金可能不足以維持目前的營運或推進一種或多種候選產品；(2)腫瘤藥物SC291、SC379和SG299的前景不如被告向投資人所宣稱的那樣樂觀；(3)為了節省資金並推進更有潛力的候選產品，Sana可能減少對腫瘤藥物SC291、SC379和SG299的資金投入和/或終止這些專案，並大幅裁員；...

LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced new data in two poster presentations at the ATS International Conference 2025. Data presented were from the Phase 3 IMPALA-2 clinical trial of molgramostim in aPAP and demonstrated that molgramostim reduces surfactant burden and improves health-related quality of life outcomes in patients with aPAP. ATS 2025 Posters Poster Ti...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ: DNUT) securities between February 25, 2025 and May 7, 2025, inclusive (the “Class Period”). Krispy Kreme investors have until July 15, 2025 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN KRISPY KREME, INC. (DNUT), CONTACT THE LAW OFFICES OF HOWARD G. S...

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Elevance business and prospects, resulting in its stock trading at inflated prices....

BERKELEY, Calif.--(BUSINESS WIRE)--IMVARIA Inc., a health tech company pioneering AI-driven digital biomarker solutions, today reported results from multi-site clinical experiences with IMVARIA’s diagnostic referral service, where pulmonologists send cases for AI-supported diagnostic evaluation of suspected Interstitial Lung Disease (ILD) and Idiopathic Pulmonary Fibrosis (IPF). Built by medical doctors with software engineering expertise, Fibresolve is the first ever FDA-authorized AI adjuncti...

MCLEAN, Va.--(BUSINESS WIRE)--Capital One Financial Corporation (NYSE: COF) today announced that it has completed its acquisition of Discover Financial Services. “This deal brings together two innovative, mission-driven companies that together are poised to deliver breakthrough products and experiences to consumers, businesses, and merchants,” said Richard D. Fairbank, Founder and CEO of Capital One. “I am particularly grateful for the leadership and partnership of Discover’s Board of Directors...

纽约--(BUSINESS WIRE)--(美国商业资讯)-- 全球投资者权益律师事务所Rosen Law Firm提醒投资者，一名股东代表在2023年3月17日至2024年11月17日期间购买Sana Biotechnology, Inc.（NASDAQ：SANA）证券的投资者提起集体诉讼。Sana是一家生物技术公司。 如需了解更多信息，请提交表格，向Phillip Kim律师发送电子邮件或致电866-767-3653联系我们。 指控内容：Rosen Law Firm正在调查有关Sana Biotechnology, Inc. （NASDAQ: SANA）在业务运营方面误导投资者的指控。 起诉书称，在集体诉讼期间，被告作出了虚假和/或误导性陈述和/或未能披露以下事实： (1) Sana面临资金不足，无法维持当前运营和推进一个或多个候选产品的的重大风险；(2) SC291（肿瘤学领域）、SC379和SG299的实际前景不如被告方此前向投资者所宣称的那样乐观；(3) 为了保留现金和推进更有前景的候选产品，Sana可能会减少对SC291（肿瘤学领域）、SC379和SG299的资助和/或停止...

ST. LOUIS--(BUSINESS WIRE)--U-Haul® has made 24 Company stores across three states available to help storm victims with 30 days of free self-storage and U-Box® container usage after a powerful weather system spawned a number of deadly tornadoes on Friday. The tornadoes tore through homes — and in some cases communities — while being responsible for more than 20 casualties, according to news reports. Many families remain without power and face a long rebuilding process. While St. Louis and other...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers and acquirers of Sana Biotechnology, Inc. (NASDAQ: SANA) securities between March 17, 2023 and November 17, 2024. Sana is a biotechnology company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Sana Biotechnology, In...